DERMOVATE 0.05% Cream drug uses, side effects , price in UAE 2023

DERMOVATE 0.05% Cream Price, Uses, Alternatives, Dose, and more in UAE 2023

DERMOVATE 0.05% Cream

DERMOVATE 0.05% Cream Price

DERMOVATE 0.05% Cream

Last update
3/9/2023, 1:09:51 AM

Price, active substance, and uses of DERMOVATE 0.05% Cream


AED 18

Drug name DERMOVATE 0.05%

Active substance Clobetasol propionate

Size : 30g Collapsible Aluminium Tube

Concentration: 0.5mg/g

Type: Cream


Import: UK

Uploaded By : Admin

ٍ Visits : 262 visit


The drug is available in the form of cream and ointment

It contains the active ingredient clobetasol propionate

It is used to treat psoriasis, skin infections and itching

Ingredients of dermovate cream and ointment

Clobetasol propionate:

It is a drug that belongs to a class of drugs called corticosteroids (which are man-made drugs similar to cortisone) and helps reduce inflammation by stopping some chemicals that cause blood vessels to dilate and cause inflammation, redness and swelling of the skin, and therefore when the effect of these chemicals is stopped, inflammation, swelling and redness decrease. and itching.

All you need to know about DERMOVATE 0.05% Cream

Welcome to Dwaey, specifically on DERMOVATE 0.05% Cream page.
This medicine contains an important and useful components, as it consists of Clobetasol propionate.
DERMOVATE 0.05% is available in the market in concentration 0.5mg/g and in the form of Cream.
GLAXO WELLCOME OPERATIONS is the producer of DERMOVATE 0.05% and it is imported from UK.
The most popular alternatives of DERMOVATE 0.05% are listed downward .

DERMOVATE 0.05% Cream Alternatives

Frequently Asked Questions

DERMOVATE 0.05% Cream for what ?

DERMOVATE 0.05% Cream uses:

Lets know how to use DERMOVATE 0.05% Cream

DERMOVATE 0.05% Cream used for:

  • Corticosteroid-responsive Dermatoses
  • Psoriasis
  • Scalp Psoriasis
  • Plaque-type Psoriasis
  • Vitiligo
  • Eczema
  • Alopecia areata
  • Herpes labialis
  • Lichen sclerosus
  • Lichen
  • Mycosis fungoides
  • Corticosteroid-responsive dermatoses

DERMOVATE 0.05% Cream side effects

  • Perioral dermatitis
  • striae esp in flexures. Dermal and epidermal atrophy esp on the face
  • steroid purpura. Burning
  • Cracking/fissuring of the skin
  • Erythema
  • Folliculitis
  • Irritation
  • Numbness
  • Pruritus
  • Stinging
  • Hypopigmentation (high potency topical steroids) Potentially Fatal: Prolonged usage of large amount of clobetasol propionate can lead to sufficient systemic levels to produce adrenal suppression
  • Cushing's syndrome
  • diabetes and hypertension.

DERMOVATE 0.05% Cream contraindications

Childn <12 yrs. Long-term treatment of ulcerative conditions, rosacea, pruritus; It is contraindicated in rosacea, acne vulgaris, perioral dermatitis, primary cutaneous viral infections (eg. herpes simplex, chickenpox), otitis externa with a perforated eardrum, hypersensitivity to the preparations. Scalp application is contraindicated in infection of the scalp.

DERMOVATE 0.05% Cream Precaution

Long-term continuous topical therapy should be avoided where possible, particularly in infants and children, as adrenal suppression can occur readily even without occlusion. If used in childhood, or on the face, courses should be limited to 5 days and occlusion should not be used. If applied to the eyelids, care is needed to ensure that the preparation does not enter the eye. If used in psoriasis careful patient supervision is important. Scalp Application: Keep away from eye. Flammable. Do not use or dry the hair near a fire or flame. Scalp Shampoo: Do not use on areas other than the scalp. Keep away from eye. Lactation: Excretion in milk unknown; use with caution

DERMOVATE 0.05% Cream Mode Of action

Clobetasol is a very potent corticosteroid used in short-term treatment of various inflammatory skin conditions. Corticosteroids decrease inflammation by stabilizing leukocyte lysosomal membranes, preventing release of destructive acid hydrolases from leukocytes; inhibiting macrophage accumulation in inflamed areas; reducing leukocyte adhesion to capillary endothelium; reducing capillary wall permeability and edema formation; decreasing complement components; antagonizing histamine activity and release of kinin from substrates; and reducing fibroblast proliferation, collagen deposition, and subsequent scar tissue formation.

DERMOVATE 0.05% Cream Interaction

Increased systemic exposure w/ CYP3A4 inhibitors (eg ritonavir & itraconazole).